Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study

Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performa...

詳細記述

書誌詳細
出版年:Cognition, Brain, Behavior. An Interdisciplinary Journal
第一著者: 2-s2.0-85048866924
フォーマット: 論文
言語:English
出版事項: ASCR Publishing House 2018
オンライン・アクセス:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045
id Chik M.W.; Hazalin N.A.M.N.; Singh G.K.S.
spelling Chik M.W.; Hazalin N.A.M.N.; Singh G.K.S.
2-s2.0-85048866924
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
2018
Cognition, Brain, Behavior. An Interdisciplinary Journal
22
1
10.24193/cbb.2018.22.02
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045
Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performance of rats when injected directly into the hippocampal region of the brain in order to mimic the pathological aspects of human Alzheimer's disease. Four months old Sprague-Dawley rats were divided into control (no treatment), two sham-operated (injected with 5 and 10 µl phosphate buffer saline respectively) and two STZ treatment groups (3 mg/kg bw; 5 µl and 6 mg/kg bw; 10 µl). STZ and vehicle were injected bilaterally as a single injection into the rats' dorsal hippocampus. After 3 months of STZ administration, the level of cognitive impairment was assessed using the Morris water maze. Both STZ-treated groups showed significant impairment on the acquisition of spatial memory (escape latency and total distance travelled) and retrieval of spatial memory (time spent in the target quadrant). However, STZ administered at 6 mg/kg bw induced severe neurotoxicity as evidenced by mortality and destruction of the brain region at the injection site with presence of large lesions. Therefore, low dose of STZ (3 mg/kg bw) administered in the intrahippocampal is sufficient to demonstrate memory impairment that can be used as a suitable rodent Alzheimer's disease model. These findings contribute in assisting researchers to decide the concentration of STZ to develop sporadic Alzheimer's disease rat model for the studies on prevention, detection and possible cure for the disease. © 2018 ASCR Publishing House. All Rights ederved.
ASCR Publishing House
22479228
English
Article

author 2-s2.0-85048866924
spellingShingle 2-s2.0-85048866924
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
author_facet 2-s2.0-85048866924
author_sort 2-s2.0-85048866924
title Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
title_short Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
title_full Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
title_fullStr Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
title_full_unstemmed Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
title_sort Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
publishDate 2018
container_title Cognition, Brain, Behavior. An Interdisciplinary Journal
container_volume 22
container_issue 1
doi_str_mv 10.24193/cbb.2018.22.02
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045
description Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performance of rats when injected directly into the hippocampal region of the brain in order to mimic the pathological aspects of human Alzheimer's disease. Four months old Sprague-Dawley rats were divided into control (no treatment), two sham-operated (injected with 5 and 10 µl phosphate buffer saline respectively) and two STZ treatment groups (3 mg/kg bw; 5 µl and 6 mg/kg bw; 10 µl). STZ and vehicle were injected bilaterally as a single injection into the rats' dorsal hippocampus. After 3 months of STZ administration, the level of cognitive impairment was assessed using the Morris water maze. Both STZ-treated groups showed significant impairment on the acquisition of spatial memory (escape latency and total distance travelled) and retrieval of spatial memory (time spent in the target quadrant). However, STZ administered at 6 mg/kg bw induced severe neurotoxicity as evidenced by mortality and destruction of the brain region at the injection site with presence of large lesions. Therefore, low dose of STZ (3 mg/kg bw) administered in the intrahippocampal is sufficient to demonstrate memory impairment that can be used as a suitable rodent Alzheimer's disease model. These findings contribute in assisting researchers to decide the concentration of STZ to develop sporadic Alzheimer's disease rat model for the studies on prevention, detection and possible cure for the disease. © 2018 ASCR Publishing House. All Rights ederved.
publisher ASCR Publishing House
issn 22479228
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1828987878485524480